Global Fragment-based Drug Discovery Market Insights, Forecast to 2029

Publisher Name :
Date: 31-May-2023
No. of pages: 111
Inquire Before Buying

The introduction of new techniques into the existing fragment-based drug discovery practices have created significant reductions in time and cost, driving the demand for such practices.

Market Analysis and Insights: Global Fragment-based Drug Discovery Market

The global Fragment-based Drug Discovery market is projected to grow from US$ 365.8 million in 2023 to US$ 533.8 million by 2029, at a Compound Annual Growth Rate (CAGR) of 6.5% during the forecast period.

The US & Canada market for Fragment-based Drug Discovery is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The China market for Fragment-based Drug Discovery is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The Europe market for Fragment-based Drug Discovery is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global key companies of Fragment-based Drug Discovery include Astex Pharmaceuticals, Alveus Pharmaceuticals, Beactica, Charles River Laboratories, Crown Bioscience, Emerald BioStructures, Evotec, Kinetic Discovery and Proteros Fragments, etc. in 2022, the global top five players had a share approximately % in terms of revenue.

Report Includes

This report presents an overview of global market for Fragment-based Drug Discovery market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Fragment-based Drug Discovery, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Fragment-based Drug Discovery, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Fragment-based Drug Discovery revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Fragment-based Drug Discovery market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Fragment-based Drug Discovery revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Astex Pharmaceuticals, Alveus Pharmaceuticals, Beactica, Charles River Laboratories, Crown Bioscience, Emerald BioStructures, Evotec, Kinetic Discovery and Proteros Fragments, etc.

By Company

- Astex Pharmaceuticals

- Alveus Pharmaceuticals

- Beactica

- Charles River Laboratories

- Crown Bioscience

- Emerald BioStructures

- Evotec

- Kinetic Discovery

- Proteros Fragments

- Sprint Bioscience

- Structure Based Design

- Sygnature Discovery

Segment by Type

- Fragment Screening

- Fragment Optimization

Segment by Application

- Academic and Research Institutions

- Biopharmaceutical Companies

- Contract Research Organizations (CROs)

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East, Africa, and Latin America

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Revenue of Fragment-based Drug Discovery in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Fragment-based Drug Discovery companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America by type, by application and by country, revenue for each segment.

Chapter 7: Europe by type, by application and by country, revenue for each segment.

Chapter 8: China by type and by application revenue for each segment.

Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.

Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Fragment-based Drug Discovery revenue, gross margin, and recent development, etc.

Chapter 12: Analyst's Viewpoints/Conclusions

Global Fragment-based Drug Discovery Market Insights, Forecast to 2029

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fragment-based Drug Discovery Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Fragment Screening
1.2.3 Fragment Optimization
1.3 Market by Application
1.3.1 Global Fragment-based Drug Discovery Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Academic and Research Institutions
1.3.3 Biopharmaceutical Companies
1.3.4 Contract Research Organizations (CROs)
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Fragment-based Drug Discovery Market Perspective (2018-2029)
2.2 Global Fragment-based Drug Discovery Growth Trends by Region
2.2.1 Fragment-based Drug Discovery Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Fragment-based Drug Discovery Historic Market Size by Region (2018-2023)
2.2.3 Fragment-based Drug Discovery Forecasted Market Size by Region (2024-2029)
2.3 Fragment-based Drug Discovery Market Dynamics
2.3.1 Fragment-based Drug Discovery Industry Trends
2.3.2 Fragment-based Drug Discovery Market Drivers
2.3.3 Fragment-based Drug Discovery Market Challenges
2.3.4 Fragment-based Drug Discovery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Fragment-based Drug Discovery by Players
3.1.1 Global Fragment-based Drug Discovery Revenue by Players (2018-2023)
3.1.2 Global Fragment-based Drug Discovery Revenue Market Share by Players (2018-2023)
3.2 Global Fragment-based Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Fragment-based Drug Discovery, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Fragment-based Drug Discovery Market Concentration Ratio
3.4.1 Global Fragment-based Drug Discovery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fragment-based Drug Discovery Revenue in 2022
3.5 Global Key Players of Fragment-based Drug Discovery Head office and Area Served
3.6 Global Key Players of Fragment-based Drug Discovery, Product and Application
3.7 Global Key Players of Fragment-based Drug Discovery, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Fragment-based Drug Discovery Breakdown Data by Type
4.1 Global Fragment-based Drug Discovery Historic Market Size by Type (2018-2023)
4.2 Global Fragment-based Drug Discovery Forecasted Market Size by Type (2024-2029)
5 Fragment-based Drug Discovery Breakdown Data by Application
5.1 Global Fragment-based Drug Discovery Historic Market Size by Application (2018-2023)
5.2 Global Fragment-based Drug Discovery Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Fragment-based Drug Discovery Market Size (2018-2029)
6.2 North America Fragment-based Drug Discovery Market Size by Type
6.2.1 North America Fragment-based Drug Discovery Market Size by Type (2018-2023)
6.2.2 North America Fragment-based Drug Discovery Market Size by Type (2024-2029)
6.2.3 North America Fragment-based Drug Discovery Market Share by Type (2018-2029)
6.3 North America Fragment-based Drug Discovery Market Size by Application
6.3.1 North America Fragment-based Drug Discovery Market Size by Application (2018-2023)
6.3.2 North America Fragment-based Drug Discovery Market Size by Application (2024-2029)
6.3.3 North America Fragment-based Drug Discovery Market Share by Application (2018-2029)
6.4 North America Fragment-based Drug Discovery Market Size by Country
6.4.1 North America Fragment-based Drug Discovery Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Fragment-based Drug Discovery Market Size by Country (2018-2023)
6.4.3 North America Fragment-based Drug Discovery Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Fragment-based Drug Discovery Market Size (2018-2029)
7.2 Europe Fragment-based Drug Discovery Market Size by Type
7.2.1 Europe Fragment-based Drug Discovery Market Size by Type (2018-2023)
7.2.2 Europe Fragment-based Drug Discovery Market Size by Type (2024-2029)
7.2.3 Europe Fragment-based Drug Discovery Market Share by Type (2018-2029)
7.3 Europe Fragment-based Drug Discovery Market Size by Application
7.3.1 Europe Fragment-based Drug Discovery Market Size by Application (2018-2023)
7.3.2 Europe Fragment-based Drug Discovery Market Size by Application (2024-2029)
7.3.3 Europe Fragment-based Drug Discovery Market Share by Application (2018-2029)
7.4 Europe Fragment-based Drug Discovery Market Size by Country
7.4.1 Europe Fragment-based Drug Discovery Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Fragment-based Drug Discovery Market Size by Country (2018-2023)
7.4.3 Europe Fragment-based Drug Discovery Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Fragment-based Drug Discovery Market Size (2018-2029)
8.2 China Fragment-based Drug Discovery Market Size by Type
8.2.1 China Fragment-based Drug Discovery Market Size by Type (2018-2023)
8.2.2 China Fragment-based Drug Discovery Market Size by Type (2024-2029)
8.2.3 China Fragment-based Drug Discovery Market Share by Type (2018-2029)
8.3 China Fragment-based Drug Discovery Market Size by Application
8.3.1 China Fragment-based Drug Discovery Market Size by Application (2018-2023)
8.3.2 China Fragment-based Drug Discovery Market Size by Application (2024-2029)
8.3.3 China Fragment-based Drug Discovery Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Fragment-based Drug Discovery Market Size (2018-2029)
9.2 Asia Fragment-based Drug Discovery Market Size by Type
9.2.1 Asia Fragment-based Drug Discovery Market Size by Type (2018-2023)
9.2.2 Asia Fragment-based Drug Discovery Market Size by Type (2024-2029)
9.2.3 Asia Fragment-based Drug Discovery Market Share by Type (2018-2029)
9.3 Asia Fragment-based Drug Discovery Market Size by Application
9.3.1 Asia Fragment-based Drug Discovery Market Size by Application (2018-2023)
9.3.2 Asia Fragment-based Drug Discovery Market Size by Application (2024-2029)
9.3.3 Asia Fragment-based Drug Discovery Market Share by Application (2018-2029)
9.4 Asia Fragment-based Drug Discovery Market Size by Region
9.4.1 Asia Fragment-based Drug Discovery Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Fragment-based Drug Discovery Market Size by Region (2018-2023)
9.4.3 Asia Fragment-based Drug Discovery Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Fragment-based Drug Discovery Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Fragment-based Drug Discovery Market Size by Type
10.2.1 Middle East, Africa, and Latin America Fragment-based Drug Discovery Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Fragment-based Drug Discovery Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Fragment-based Drug Discovery Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Fragment-based Drug Discovery Market Size by Application
10.3.1 Middle East, Africa, and Latin America Fragment-based Drug Discovery Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Fragment-based Drug Discovery Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Fragment-based Drug Discovery Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Fragment-based Drug Discovery Market Size by Country
10.4.1 Middle East, Africa, and Latin America Fragment-based Drug Discovery Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Fragment-based Drug Discovery Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Fragment-based Drug Discovery Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Astex Pharmaceuticals
11.1.1 Astex Pharmaceuticals Company Details
11.1.2 Astex Pharmaceuticals Business Overview
11.1.3 Astex Pharmaceuticals Fragment-based Drug Discovery Introduction
11.1.4 Astex Pharmaceuticals Revenue in Fragment-based Drug Discovery Business (2018-2023)
11.1.5 Astex Pharmaceuticals Recent Developments
11.2 Alveus Pharmaceuticals
11.2.1 Alveus Pharmaceuticals Company Details
11.2.2 Alveus Pharmaceuticals Business Overview
11.2.3 Alveus Pharmaceuticals Fragment-based Drug Discovery Introduction
11.2.4 Alveus Pharmaceuticals Revenue in Fragment-based Drug Discovery Business (2018-2023)
11.2.5 Alveus Pharmaceuticals Recent Developments
11.3 Beactica
11.3.1 Beactica Company Details
11.3.2 Beactica Business Overview
11.3.3 Beactica Fragment-based Drug Discovery Introduction
11.3.4 Beactica Revenue in Fragment-based Drug Discovery Business (2018-2023)
11.3.5 Beactica Recent Developments
11.4 Charles River Laboratories
11.4.1 Charles River Laboratories Company Details
11.4.2 Charles River Laboratories Business Overview
11.4.3 Charles River Laboratories Fragment-based Drug Discovery Introduction
11.4.4 Charles River Laboratories Revenue in Fragment-based Drug Discovery Business (2018-2023)
11.4.5 Charles River Laboratories Recent Developments
11.5 Crown Bioscience
11.5.1 Crown Bioscience Company Details
11.5.2 Crown Bioscience Business Overview
11.5.3 Crown Bioscience Fragment-based Drug Discovery Introduction
11.5.4 Crown Bioscience Revenue in Fragment-based Drug Discovery Business (2018-2023)
11.5.5 Crown Bioscience Recent Developments
11.6 Emerald BioStructures
11.6.1 Emerald BioStructures Company Details
11.6.2 Emerald BioStructures Business Overview
11.6.3 Emerald BioStructures Fragment-based Drug Discovery Introduction
11.6.4 Emerald BioStructures Revenue in Fragment-based Drug Discovery Business (2018-2023)
11.6.5 Emerald BioStructures Recent Developments
11.7 Evotec
11.7.1 Evotec Company Details
11.7.2 Evotec Business Overview
11.7.3 Evotec Fragment-based Drug Discovery Introduction
11.7.4 Evotec Revenue in Fragment-based Drug Discovery Business (2018-2023)
11.7.5 Evotec Recent Developments
11.8 Kinetic Discovery
11.8.1 Kinetic Discovery Company Details
11.8.2 Kinetic Discovery Business Overview
11.8.3 Kinetic Discovery Fragment-based Drug Discovery Introduction
11.8.4 Kinetic Discovery Revenue in Fragment-based Drug Discovery Business (2018-2023)
11.8.5 Kinetic Discovery Recent Developments
11.9 Proteros Fragments
11.9.1 Proteros Fragments Company Details
11.9.2 Proteros Fragments Business Overview
11.9.3 Proteros Fragments Fragment-based Drug Discovery Introduction
11.9.4 Proteros Fragments Revenue in Fragment-based Drug Discovery Business (2018-2023)
11.9.5 Proteros Fragments Recent Developments
11.10 Sprint Bioscience
11.10.1 Sprint Bioscience Company Details
11.10.2 Sprint Bioscience Business Overview
11.10.3 Sprint Bioscience Fragment-based Drug Discovery Introduction
11.10.4 Sprint Bioscience Revenue in Fragment-based Drug Discovery Business (2018-2023)
11.10.5 Sprint Bioscience Recent Developments
11.11 Structure Based Design
11.11.1 Structure Based Design Company Details
11.11.2 Structure Based Design Business Overview
11.11.3 Structure Based Design Fragment-based Drug Discovery Introduction
11.11.4 Structure Based Design Revenue in Fragment-based Drug Discovery Business (2018-2023)
11.11.5 Structure Based Design Recent Developments
11.12 Sygnature Discovery
11.12.1 Sygnature Discovery Company Details
11.12.2 Sygnature Discovery Business Overview
11.12.3 Sygnature Discovery Fragment-based Drug Discovery Introduction
11.12.4 Sygnature Discovery Revenue in Fragment-based Drug Discovery Business (2018-2023)
11.12.5 Sygnature Discovery Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Fragment-based Drug Discovery Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Fragment Screening
Table 3. Key Players of Fragment Optimization
Table 4. Global Fragment-based Drug Discovery Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Fragment-based Drug Discovery Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Fragment-based Drug Discovery Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Fragment-based Drug Discovery Market Share by Region (2018-2023)
Table 8. Global Fragment-based Drug Discovery Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Fragment-based Drug Discovery Market Share by Region (2024-2029)
Table 10. Fragment-based Drug Discovery Market Trends
Table 11. Fragment-based Drug Discovery Market Drivers
Table 12. Fragment-based Drug Discovery Market Challenges
Table 13. Fragment-based Drug Discovery Market Restraints
Table 14. Global Fragment-based Drug Discovery Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Fragment-based Drug Discovery Revenue Share by Players (2018-2023)
Table 16. Global Top Fragment-based Drug Discovery by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fragment-based Drug Discovery as of 2022)
Table 17. Global Fragment-based Drug Discovery Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Fragment-based Drug Discovery Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Fragment-based Drug Discovery, Headquarters and Area Served
Table 20. Global Key Players of Fragment-based Drug Discovery, Product and Application
Table 21. Global Key Players of Fragment-based Drug Discovery, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Fragment-based Drug Discovery Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Fragment-based Drug Discovery Revenue Market Share by Type (2018-2023)
Table 25. Global Fragment-based Drug Discovery Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Fragment-based Drug Discovery Revenue Market Share by Type (2024-2029)
Table 27. Global Fragment-based Drug Discovery Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Fragment-based Drug Discovery Revenue Share by Application (2018-2023)
Table 29. Global Fragment-based Drug Discovery Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Fragment-based Drug Discovery Revenue Share by Application (2024-2029)
Table 31. North America Fragment-based Drug Discovery Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Fragment-based Drug Discovery Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Fragment-based Drug Discovery Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Fragment-based Drug Discovery Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Fragment-based Drug Discovery Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Fragment-based Drug Discovery Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Fragment-based Drug Discovery Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Fragment-based Drug Discovery Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Fragment-based Drug Discovery Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Fragment-based Drug Discovery Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Fragment-based Drug Discovery Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Fragment-based Drug Discovery Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Fragment-based Drug Discovery Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Fragment-based Drug Discovery Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Fragment-based Drug Discovery Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Fragment-based Drug Discovery Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Fragment-based Drug Discovery Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Fragment-based Drug Discovery Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Fragment-based Drug Discovery Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Fragment-based Drug Discovery Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Fragment-based Drug Discovery Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Fragment-based Drug Discovery Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Fragment-based Drug Discovery Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Fragment-based Drug Discovery Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Fragment-based Drug Discovery Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Fragment-based Drug Discovery Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Fragment-based Drug Discovery Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Fragment-based Drug Discovery Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Fragment-based Drug Discovery Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Fragment-based Drug Discovery Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Fragment-based Drug Discovery Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Fragment-based Drug Discovery Market Size by Country (2024-2029) & (US$ Million)
Table 63. Astex Pharmaceuticals Company Details
Table 64. Astex Pharmaceuticals Business Overview
Table 65. Astex Pharmaceuticals Fragment-based Drug Discovery Product
Table 66. Astex Pharmaceuticals Revenue in Fragment-based Drug Discovery Business (2018-2023) & (US$ Million)
Table 67. Astex Pharmaceuticals Recent Developments
Table 68. Alveus Pharmaceuticals Company Details
Table 69. Alveus Pharmaceuticals Business Overview
Table 70. Alveus Pharmaceuticals Fragment-based Drug Discovery Product
Table 71. Alveus Pharmaceuticals Revenue in Fragment-based Drug Discovery Business (2018-2023) & (US$ Million)
Table 72. Alveus Pharmaceuticals Recent Developments
Table 73. Beactica Company Details
Table 74. Beactica Business Overview
Table 75. Beactica Fragment-based Drug Discovery Product
Table 76. Beactica Revenue in Fragment-based Drug Discovery Business (2018-2023) & (US$ Million)
Table 77. Beactica Recent Developments
Table 78. Charles River Laboratories Company Details
Table 79. Charles River Laboratories Business Overview
Table 80. Charles River Laboratories Fragment-based Drug Discovery Product
Table 81. Charles River Laboratories Revenue in Fragment-based Drug Discovery Business (2018-2023) & (US$ Million)
Table 82. Charles River Laboratories Recent Developments
Table 83. Crown Bioscience Company Details
Table 84. Crown Bioscience Business Overview
Table 85. Crown Bioscience Fragment-based Drug Discovery Product
Table 86. Crown Bioscience Revenue in Fragment-based Drug Discovery Business (2018-2023) & (US$ Million)
Table 87. Crown Bioscience Recent Developments
Table 88. Emerald BioStructures Company Details
Table 89. Emerald BioStructures Business Overview
Table 90. Emerald BioStructures Fragment-based Drug Discovery Product
Table 91. Emerald BioStructures Revenue in Fragment-based Drug Discovery Business (2018-2023) & (US$ Million)
Table 92. Emerald BioStructures Recent Developments
Table 93. Evotec Company Details
Table 94. Evotec Business Overview
Table 95. Evotec Fragment-based Drug Discovery Product
Table 96. Evotec Revenue in Fragment-based Drug Discovery Business (2018-2023) & (US$ Million)
Table 97. Evotec Recent Developments
Table 98. Kinetic Discovery Company Details
Table 99. Kinetic Discovery Business Overview
Table 100. Kinetic Discovery Fragment-based Drug Discovery Product
Table 101. Kinetic Discovery Revenue in Fragment-based Drug Discovery Business (2018-2023) & (US$ Million)
Table 102. Kinetic Discovery Recent Developments
Table 103. Proteros Fragments Company Details
Table 104. Proteros Fragments Business Overview
Table 105. Proteros Fragments Fragment-based Drug Discovery Product
Table 106. Proteros Fragments Revenue in Fragment-based Drug Discovery Business (2018-2023) & (US$ Million)
Table 107. Proteros Fragments Recent Developments
Table 108. Sprint Bioscience Company Details
Table 109. Sprint Bioscience Business Overview
Table 110. Sprint Bioscience Fragment-based Drug Discovery Product
Table 111. Sprint Bioscience Revenue in Fragment-based Drug Discovery Business (2018-2023) & (US$ Million)
Table 112. Sprint Bioscience Recent Developments
Table 113. Structure Based Design Company Details
Table 114. Structure Based Design Business Overview
Table 115. Structure Based Design Fragment-based Drug Discovery Product
Table 116. Structure Based Design Revenue in Fragment-based Drug Discovery Business (2018-2023) & (US$ Million)
Table 117. Structure Based Design Recent Developments
Table 118. Sygnature Discovery Company Details
Table 119. Sygnature Discovery Business Overview
Table 120. Sygnature Discovery Fragment-based Drug Discovery Product
Table 121. Sygnature Discovery Revenue in Fragment-based Drug Discovery Business (2018-2023) & (US$ Million)
Table 122. Sygnature Discovery Recent Developments
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Fragment-based Drug Discovery Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Fragment-based Drug Discovery Market Share by Type: 2022 VS 2029
Figure 3. Fragment Screening Features
Figure 4. Fragment Optimization Features
Figure 5. Global Fragment-based Drug Discovery Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Fragment-based Drug Discovery Market Share by Application: 2022 VS 2029
Figure 7. Academic and Research Institutions Case Studies
Figure 8. Biopharmaceutical Companies Case Studies
Figure 9. Contract Research Organizations (CROs) Case Studies
Figure 10. Fragment-based Drug Discovery Report Years Considered
Figure 11. Global Fragment-based Drug Discovery Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Fragment-based Drug Discovery Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Fragment-based Drug Discovery Market Share by Region: 2022 VS 2029
Figure 14. Global Fragment-based Drug Discovery Market Share by Players in 2022
Figure 15. Global Top Fragment-based Drug Discovery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fragment-based Drug Discovery as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Fragment-based Drug Discovery Revenue in 2022
Figure 17. North America Fragment-based Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Fragment-based Drug Discovery Market Share by Type (2018-2029)
Figure 19. North America Fragment-based Drug Discovery Market Share by Application (2018-2029)
Figure 20. North America Fragment-based Drug Discovery Market Share by Country (2018-2029)
Figure 21. United States Fragment-based Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Fragment-based Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Fragment-based Drug Discovery Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe Fragment-based Drug Discovery Market Share by Type (2018-2029)
Figure 25. Europe Fragment-based Drug Discovery Market Share by Application (2018-2029)
Figure 26. Europe Fragment-based Drug Discovery Market Share by Country (2018-2029)
Figure 27. Germany Fragment-based Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Fragment-based Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Fragment-based Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Fragment-based Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Fragment-based Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Fragment-based Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China Fragment-based Drug Discovery Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China Fragment-based Drug Discovery Market Share by Type (2018-2029)
Figure 35. China Fragment-based Drug Discovery Market Share by Application (2018-2029)
Figure 36. Asia Fragment-based Drug Discovery Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia Fragment-based Drug Discovery Market Share by Type (2018-2029)
Figure 38. Asia Fragment-based Drug Discovery Market Share by Application (2018-2029)
Figure 39. Asia Fragment-based Drug Discovery Market Share by Region (2018-2029)
Figure 40. Japan Fragment-based Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Fragment-based Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan Fragment-based Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Fragment-based Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Fragment-based Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Fragment-based Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Fragment-based Drug Discovery Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Fragment-based Drug Discovery Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America Fragment-based Drug Discovery Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America Fragment-based Drug Discovery Market Share by Country (2018-2029)
Figure 50. Brazil Fragment-based Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico Fragment-based Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey Fragment-based Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Fragment-based Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel Fragment-based Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries Fragment-based Drug Discovery Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Astex Pharmaceuticals Revenue Growth Rate in Fragment-based Drug Discovery Business (2018-2023)
Figure 57. Alveus Pharmaceuticals Revenue Growth Rate in Fragment-based Drug Discovery Business (2018-2023)
Figure 58. Beactica Revenue Growth Rate in Fragment-based Drug Discovery Business (2018-2023)
Figure 59. Charles River Laboratories Revenue Growth Rate in Fragment-based Drug Discovery Business (2018-2023)
Figure 60. Crown Bioscience Revenue Growth Rate in Fragment-based Drug Discovery Business (2018-2023)
Figure 61. Emerald BioStructures Revenue Growth Rate in Fragment-based Drug Discovery Business (2018-2023)
Figure 62. Evotec Revenue Growth Rate in Fragment-based Drug Discovery Business (2018-2023)
Figure 63. Kinetic Discovery Revenue Growth Rate in Fragment-based Drug Discovery Business (2018-2023)
Figure 64. Proteros Fragments Revenue Growth Rate in Fragment-based Drug Discovery Business (2018-2023)
Figure 65. Sprint Bioscience Revenue Growth Rate in Fragment-based Drug Discovery Business (2018-2023)
Figure 66. Structure Based Design Revenue Growth Rate in Fragment-based Drug Discovery Business (2018-2023)
Figure 67. Sygnature Discovery Revenue Growth Rate in Fragment-based Drug Discovery Business (2018-2023)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
  • Global High Content Screening Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 124
    Report Overview: High-content screening (HCS) or high-content analysis (HCA) (also known as cellomics), is a set of analytical techniques that is applied in genetic research and drug discovery processes in order to recognize elements such as peptides, small molecules, or genetic materials (such as RNAi) that have the potential to modify the phenotype of a cell in a certain manner. High-content screening employs a set of analytical procedures such as multi-parameter image processing, automa......
  • Global Fragment-Based Drug Discovery Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 108
    Market Overview of Global Fragment-Based Drug Discovery market: According to our latest research, the global Fragment-Based Drug Discovery market looks promising in the next 5 years. As of 2022, the global Fragment-Based Drug Discovery market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......
  • Global High Throughput Screening Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Nov-2023        Price: US 3380 Onwards        Pages: 111
    Market Overview of Global High Throughput Screening market: According to our latest research, the global High Throughput Screening market looks promising in the next 5 years. As of 2022, the global High Throughput Screening market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. High throughput screening refers to the experimental method based on molecular and cellular levels, using microplate......
  • Global High Content Screening Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 09-Nov-2023        Price: US 3380 Onwards        Pages: 111
    Market Overview of Global High Content Screening market: According to our latest research, the global High Content Screening market looks promising in the next 5 years. As of 2022, the global High Content Screening market was estimated at USD 579.78 million, and it's anticipated to reach USD 1216.18 million in 2028, with a CAGR of 13.14% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the ......
  • Global Botanical and Plant Derived Drugs Market Insights, Forecast to 2029
    Published: 14-Aug-2023        Price: US 4900 Onwards        Pages: 88
    Botanical drugs are those drugs which are derived from medicinal plants. Plant derived drugs are combination of botanical as well as other approved drugs that contains plant materials, synthetic and semi synthetic substances. Botanical drugs consist of vegetable material, algae and macroscopic fungi. They are used in treatment of various diseases, such as central nervous system disorders, cardiovascular diseases, infectious diseases and respiratory diseases. Botanical drugs are available in vari......
  • Global High Content Screening Market Insights, Forecast to 2029
    Published: 11-Aug-2023        Price: US 4900 Onwards        Pages: 110
    High-content screening (HCS) or high-content analysis (HCA) (also known as cellomics), is a set of analytical techniques that is applied in genetic research and drug discovery processes in order to recognize elements such as peptides, small molecules, or genetic materials (such as RNAi) that have the potential to modify the phenotype of a cell in a certain manner. High-content screening employs a set of analytical procedures such as multi-parameter image processing, automated microscopy, fluores......
  • Global High Throughput Screening Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 27-Jun-2023        Price: US 3260 Onwards        Pages: 115
    High throughput screening refers to the experimental method based on molecular and cellular levels, using microplate as an experimental tool carrier, performing the test process with an automated operating system, collecting experimental results data with sensitive and rapid detection instruments, and processing experiments with computer analysis. Data, testing tens of millions of samples at the same time, and supporting the running technical system with the corresponding database, it is charact......
  • Global Fragment-based Drug Discovery Market Insights, Forecast to 2029
    Published: 31-May-2023        Price: US 4900 Onwards        Pages: 111
    The introduction of new techniques into the existing fragment-based drug discovery practices have created significant reductions in time and cost, driving the demand for such practices. Market Analysis and Insights: Global Fragment-based Drug Discovery Market The global Fragment-based Drug Discovery market is projected to grow from US$ 365.8 million in 2023 to US$ 533.8 million by 2029, at a Compound Annual Growth Rate (CAGR) of 6.5% during the forecast period. The US & Cana......
  • High Throughput Screening Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030
    Published: 05-May-2023        Price: US 4150 Onwards        Pages: 146
    The study predicts the short term and long term trends that can shape up the future of the High Throughput Screening market including the COVID-19 pandemic implications for High Throughput Screenings industry. The report presents market size forecasts across types, applications, end users and countries across regions. Strategic imperatives for development managers, decision makers and industry professionals including market trends, drivers, challenges, five forces analysis, insights on markets a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs